BBH vs. CANC ETF Comparison
Comparison of Market Vectors Biotech ETF (BBH) to Tema Oncology ETF (CANC)
BBH
Market Vectors Biotech ETF
BBH Description
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include small- and medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Grade (RS Rating)
Last Trade
$163.79
Average Daily Volume
7,642
25
CANC
Tema Oncology ETF
CANC Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.Grade (RS Rating)
Last Trade
$27.48
Average Daily Volume
536
7
Performance
| Period | BBH | CANC |
|---|---|---|
| 30 Days | 1.99% | 1.66% |
| 60 Days | -0.66% | -2.41% |
| 90 Days | -1.60% | 1.40% |
| 12 Months | 2.42% |
BBH Overweight 20 Positions Relative to CANC
BBH: Top Represented Industries & Keywords
CANC: Top Represented Industries & Keywords
Compare ETFs
